An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Drugs and Lactation Database (LactMed®) [Internet].
Bethesda (MD): National Institute of Child Health and Human Development; 2006-.
Top results in this bookTable of Contents
Preventive Pharmacological Treatments for Migraine in Adults: Future Research Needs: Identification of Future Research Needs From Comparative Effectiveness Review No. 103 [Internet].
Brasure M, Shamliyan TA, Butler ME, et al.
Rockville (MD): Agency for Healthcare Research and Quality (US); 2013 Apr. (Future Research Needs Papers, No. 35.)
Eptinezumab (Vyepti): CADTH Reimbursement Review: Therapeutic area: Migraine [Internet].
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2023 Mar.
Galcanezumab (Emgality): CADTH Reimbursement Review: Therapeutic area: Prevention of migraine [Internet].
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2022 Mar.
Atogepant (Qulipta): CADTH Reimbursement Review: Therapeutic area: Migraine, prevention [Internet].
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2023 Aug.
InformedHealth.org [Internet].
Cologne, Germany: Institute for Quality and Efficiency in Health Care (IQWiG); 2006-.
Pharmacoeconomic Review Report: OnabotulinumtoxinA (Botox): (Allergan Inc.): Indication: For the prophylaxis of headaches in adults with chronic migraine (≥ 15 days per month with headache lasting four hours a day or longer) [Internet].
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2019 Nov.
Pharmacoeconomic Review Report: Erenumab (Aimovig): (Novartis Pharmaceuticals Canada Inc.): Indication: For prevention of migraine in adults who have had at least four migraine days monthly [Internet].
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2020 Sep.
OnabotulinumtoxinA for Injection (Botox): For the Prophylaxis of Headaches in Adults With Chronic Migraine (≥ 15 Days per Month With Headache Lasting 4 Hours a Day or Longer) [Internet].
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2015 Jul.
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on